Laboratory of Molecular Gerontology, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224, United States.
Mutat Res. 2011 Jun 3;711(1-2):100-12. doi: 10.1016/j.mrfmmm.2010.12.004. Epub 2010 Dec 15.
The major DNA repair pathway for coping with spontaneous forms of DNA damage, such as natural hydrolytic products or oxidative lesions, is base excision repair (BER). In particular, BER processes mutagenic and cytotoxic DNA lesions such as non-bulky base modifications, abasic sites, and a range of chemically distinct single-strand breaks. Defects in BER have been linked to cancer predisposition, neurodegenerative disorders, and immunodeficiency. Recent data indicate a large degree of sequence variability in DNA repair genes and several studies have associated BER gene polymorphisms with disease risk, including cancer of several sites. The intent of this review is to describe the range of BER capacity among individuals and the functional consequences of BER genetic variants. We also discuss studies that associate BER deficiency with disease risk and the current state of BER capacity measurement assays.
应对自发性 DNA 损伤(如天然水解产物或氧化损伤)的主要 DNA 修复途径是碱基切除修复 (BER)。特别是,BER 过程处理诱变和细胞毒性 DNA 损伤,如非大量碱基修饰、无碱基位点和一系列化学上不同的单链断裂。BER 缺陷与癌症易感性、神经退行性疾病和免疫缺陷有关。最近的数据表明 DNA 修复基因存在很大程度的序列变异性,并且有几项研究将 BER 基因多态性与疾病风险(包括多个部位的癌症)相关联。本综述旨在描述个体之间的 BER 能力范围以及 BER 遗传变异的功能后果。我们还讨论了将 BER 缺陷与疾病风险相关联的研究以及当前的 BER 能力测量测定方法。